ExodusPoint Capital Management LP bought a new position in shares of Enhabit, Inc. (NYSE:EHAB - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 75,952 shares of the company's stock, valued at approximately $593,000. ExodusPoint Capital Management LP owned approximately 0.15% of Enhabit at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Franklin Resources Inc. grew its stake in shares of Enhabit by 19.6% during the 3rd quarter. Franklin Resources Inc. now owns 32,382 shares of the company's stock worth $256,000 after acquiring an additional 5,317 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in Enhabit by 37.8% during the third quarter. JPMorgan Chase & Co. now owns 305,245 shares of the company's stock worth $2,411,000 after purchasing an additional 83,707 shares during the last quarter. Paradice Investment Management LLC increased its stake in Enhabit by 12.8% in the 4th quarter. Paradice Investment Management LLC now owns 1,780,113 shares of the company's stock valued at $13,903,000 after buying an additional 201,997 shares during the last quarter. XTX Topco Ltd bought a new stake in Enhabit during the 3rd quarter worth about $123,000. Finally, Jane Street Group LLC grew its holdings in shares of Enhabit by 514.3% in the 3rd quarter. Jane Street Group LLC now owns 901,084 shares of the company's stock valued at $7,119,000 after acquiring an additional 754,395 shares in the last quarter.
Wall Street Analysts Forecast Growth
Separately, Jefferies Financial Group reissued a "buy" rating on shares of Enhabit in a report on Thursday, March 6th.
Check Out Our Latest Stock Analysis on Enhabit
Enhabit Stock Performance
NYSE:EHAB traded down $0.05 during mid-day trading on Thursday, reaching $7.65. 80,517 shares of the company's stock were exchanged, compared to its average volume of 481,219. Enhabit, Inc. has a one year low of $6.85 and a one year high of $10.70. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.46 and a current ratio of 1.46. The business's fifty day simple moving average is $8.45 and its two-hundred day simple moving average is $7.99. The firm has a market capitalization of $386.17 million, a PE ratio of -3.31 and a beta of 1.60.
Enhabit Profile
(
Free Report)
Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.
See Also
Before you consider Enhabit, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enhabit wasn't on the list.
While Enhabit currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
